CSI Market
Sign In | Register

Carlsmed Inc (CARL) Annual Income Statement

Annual · GAAP · USD millions
Access CARL quarterly income statements →
The data below summarizes Carlsmed Inc's income statement results from to Dec 31 2025, enabling period-by-period comparison of operating performance.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
2025
Revenues
Sales of Products50.51
Total Revenue50.04
Costs & Expenses
Cost of Goods and Services Sold12.00
Gross Profit38.04
Selling, Administration, Marketing35.03
Research and Development Expense17.02
Other Operating Expense / -Income16.57
Total operating costs including COS80.61
Operating income / -loss-30.57
Interest Expense1.43
Net Interest (-)Expense / Income-1.43
Investment Income, Interest-2.70
Other loss / -income0.33
Total costs & expenses79.67
Income & Taxes
Income / -loss before income taxes-29.63
Income after income taxes-29.63
Income / -loss from continuing operations-29.63
Preferred dividends-0.58
Net income / -loss-29.63
Income / -loss to shareholder-30.22
EBIT-28.20
EBITD-27.92
EBITDA-27.92
Earnings Per Share
Basic EPS (excl. extra items)-2.12
Basic Net EPS-2.12
Basic shares outstanding (Mill. of Units)14.22
Diluted Net EPS-2.12
Diluted average shares (Mill. of Units)14.22
4 historic quarters locked

Sign in to unlock the full Carlsmed Inc income statement history.

Sign In Create Free Account

About Carlsmed Inc Annual Income Statement

What this statement shows

This page presents issuer-reported income statement data, detailing revenue, operating costs, expenses, and earnings as disclosed in SEC 10-K filings and standardized by CSIMarket. The income statement reflects operating performance over a reporting period rather than financial position at a single date.

Revenue and expense treatment

Revenue and expense items are aligned to support period-to-period comparability. Operating and non-operating items, interest, and income taxes are classified based on issuer disclosures and XBRL tagging.

Source & verification

  • Source: SEC 10-K filings
  • Filed with the SEC: February 25, 2026
  • Original filing: carl-20251231.htm

Income statement figures represent operating results for each reporting period and may be revised in subsequent filings.